News | News By Subject | News by Disease News By Date | Search News

Chronic Idiopathic Urticaria (CIU)(Hives) News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Novartis AG (NVS) Announces FDA Approval Of Xolair® (Omalizumab) For Chronic Idiopathic Urticaria (CIU), A Form Of Chronic Hives     3/24/2014
FDA Files Genentech (RHHBY)'s Supplemental Biologics License Application of Xolair®     10/11/2013
Teva Pharmaceutical Industries Limited (TEVA) Announces Tentative Approval Of Cetirizine HCL Tablets     9/22/2004
Schering-Plough Corporation (SGP) Release: FDA Approves CLARINEX(R) (Desloratadine) Syrup For Relief Of Symptoms Associated With Indoor And Outdoor Allergies And Hives In Children     9/2/2004

News from Around the Web

Press Releases